Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7783536rdf:typepubmed:Citationlld:pubmed
pubmed-article:7783536lifeskim:mentionsumls-concept:C0024141lld:lifeskim
pubmed-article:7783536lifeskim:mentionsumls-concept:C0035020lld:lifeskim
pubmed-article:7783536lifeskim:mentionsumls-concept:C1708528lld:lifeskim
pubmed-article:7783536pubmed:issue8965lld:pubmed
pubmed-article:7783536pubmed:dateCreated1995-7-17lld:pubmed
pubmed-article:7783536pubmed:abstractTextMany relapses of systemic lupus erythematosus (SLE) are preceded by a rise in antibodies against double-stranded DNA (anti-dsDNA). We investigated whether these relapses can be prevented by giving prednisone when a rise in anti-dsDNA occurs. 156 patients with SLE were studied. Anti-dsDNA was measured by Farr assay monthly. When a rise in anti-dsDNA was found, patients were randomly assigned either conventional treatment or 30 mg prednisone added to the current daily dose and tapering off to baseline over 18 weeks. A rise in anti-dsDNA was detected in 46 patients (24 assigned conventional treatment and 22 prednisolone). The relapse rate was higher in the conventional group than in the prednisolone group (20 vs 2, p < 0.001). Although rises in anti-dsDNA in the prednisone group were treated with additional prednisone, the cumulative oral doses of prednisone in the two groups did not differ significantly (p = 0.025). 7 major relapses requiring additional cytotoxic immunosuppressive treatment occurred in the conventional group versus 2 in the prednisone group. Treatment with prednisone as soon as a significant rise in anti-dsDNA occurs prevents relapse in most cases, without increasing the cumulative dose of prednisdone given.lld:pubmed
pubmed-article:7783536pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7783536pubmed:languageenglld:pubmed
pubmed-article:7783536pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7783536pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7783536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7783536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7783536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7783536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7783536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7783536pubmed:statusMEDLINElld:pubmed
pubmed-article:7783536pubmed:monthJunlld:pubmed
pubmed-article:7783536pubmed:issn0140-6736lld:pubmed
pubmed-article:7783536pubmed:authorpubmed-author:HermannMMlld:pubmed
pubmed-article:7783536pubmed:authorpubmed-author:KaterLLlld:pubmed
pubmed-article:7783536pubmed:authorpubmed-author:Gmelig-Meylin...lld:pubmed
pubmed-article:7783536pubmed:authorpubmed-author:KallenbergCClld:pubmed
pubmed-article:7783536pubmed:authorpubmed-author:de BoerGGlld:pubmed
pubmed-article:7783536pubmed:authorpubmed-author:LimburgPPlld:pubmed
pubmed-article:7783536pubmed:authorpubmed-author:BootsmaHHlld:pubmed
pubmed-article:7783536pubmed:authorpubmed-author:SpronkPPlld:pubmed
pubmed-article:7783536pubmed:authorpubmed-author:DerksenRRlld:pubmed
pubmed-article:7783536pubmed:authorpubmed-author:Wolters-Dicke...lld:pubmed
pubmed-article:7783536pubmed:issnTypePrintlld:pubmed
pubmed-article:7783536pubmed:day24lld:pubmed
pubmed-article:7783536pubmed:volume345lld:pubmed
pubmed-article:7783536pubmed:ownerNLMlld:pubmed
pubmed-article:7783536pubmed:authorsCompleteYlld:pubmed
pubmed-article:7783536pubmed:pagination1595-9lld:pubmed
pubmed-article:7783536pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7783536pubmed:meshHeadingpubmed-meshheading:7783536-...lld:pubmed
pubmed-article:7783536pubmed:meshHeadingpubmed-meshheading:7783536-...lld:pubmed
pubmed-article:7783536pubmed:meshHeadingpubmed-meshheading:7783536-...lld:pubmed
pubmed-article:7783536pubmed:meshHeadingpubmed-meshheading:7783536-...lld:pubmed
pubmed-article:7783536pubmed:meshHeadingpubmed-meshheading:7783536-...lld:pubmed
pubmed-article:7783536pubmed:meshHeadingpubmed-meshheading:7783536-...lld:pubmed
pubmed-article:7783536pubmed:meshHeadingpubmed-meshheading:7783536-...lld:pubmed
pubmed-article:7783536pubmed:meshHeadingpubmed-meshheading:7783536-...lld:pubmed
pubmed-article:7783536pubmed:meshHeadingpubmed-meshheading:7783536-...lld:pubmed
pubmed-article:7783536pubmed:meshHeadingpubmed-meshheading:7783536-...lld:pubmed
pubmed-article:7783536pubmed:meshHeadingpubmed-meshheading:7783536-...lld:pubmed
pubmed-article:7783536pubmed:meshHeadingpubmed-meshheading:7783536-...lld:pubmed
pubmed-article:7783536pubmed:meshHeadingpubmed-meshheading:7783536-...lld:pubmed
pubmed-article:7783536pubmed:meshHeadingpubmed-meshheading:7783536-...lld:pubmed
pubmed-article:7783536pubmed:meshHeadingpubmed-meshheading:7783536-...lld:pubmed
pubmed-article:7783536pubmed:year1995lld:pubmed
pubmed-article:7783536pubmed:articleTitlePrevention of relapses in systemic lupus erythematosus.lld:pubmed
pubmed-article:7783536pubmed:affiliationDepartment of Internal Medicine, University Hospital Groningen, Netherlands.lld:pubmed
pubmed-article:7783536pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7783536pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:7783536pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:7783536pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7783536lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7783536lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7783536lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7783536lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7783536lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7783536lld:pubmed